Galmed Pharmaceuticals (GLMD) Return on Capital Employed Growth (1y) (2015 - 2020)
Galmed Pharmaceuticals (GLMD) Return on Capital Employed Growth (1y) (2015 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
31,429.00 |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
16,829.00 |
| 10 |
Galmed Pharmaceuticals |
2.48 Mn |
-1.63 Mn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2020 |
2,180.00 |
| Dec 31, 2019 |
1,780.00 |
| Sep 30, 2019 |
589.00 |
| Mar 31, 2019 |
-6,423.00 |
| Dec 31, 2018 |
-10,443.00 |
| Sep 30, 2018 |
-18,946.00 |
| Jun 30, 2018 |
-16,764.00 |
| Mar 31, 2018 |
-7,401.00 |
| Dec 31, 2017 |
-1,224.00 |
| Sep 30, 2017 |
10,309.00 |
| Jun 30, 2017 |
10,349.00 |
| Sep 30, 2016 |
6,075.00 |
| Jun 30, 2016 |
5,095.00 |
| Sep 30, 2015 |
1,241.00 |
| Jun 30, 2015 |
2,135.00 |
